Butyrylcholinesterase levels correlate with surgical site infection risk and severity after colorectal surgery: a prospective single-center study.

Georgios-Ioannis Verras, Francesk Mulita
Author Information
  1. Georgios-Ioannis Verras: Department of General Surgery, University Hospital Southampton, NHS Trust, Southampton, United Kingdom.
  2. Francesk Mulita: Department of Surgery, General University Hospital of Patras, Patras, Greece.

Abstract

Introduction: Surgical site infections (SSIs) after colorectal surgery remain a significant concern, which warrants effective predictive markers for prompt diagnosis and treatment. Butyrylcholinesterase (BChE), a non-specific cholinesterase enzyme, has been correlated with the risk of hepatic dysfunction progression and, more recently, infectious diseases and septic shock with ongoing research into the utility of BChE in multiple systemic inflammatory conditions. Whether these preliminary results can be translated into predicting infection after colorectal surgery remains in remains in question. This prospective study aimed to assess BChE's potential as a predictive marker for surgical site infections and anastomotic leaks after colorectal surgery.
Materials and methods: This single-center prospective study (11/2019-05/2023) enrolled 402 patients who underwent colorectal surgery. BChE levels were measured at four postoperative time points. The primary endpoints focused on BChE's association with complications, particularly surgical site infections (SSIs). Further known predictors of SSI were utilized to construct multivariable models to assess for independent association with SSI development.
Results: During the third and fifth day postsurgery, SSI patients had significantly lower mean BChE levels (3.90���KU/L vs. 4.54���KU/L -value���<���0.05, and 4.14���KU/L vs. 4.73���KU/L, -value���<���0.05; -test, respectively). However, multivariate analysis revealed that when adjusted for other factors, low BChE levels on the first postoperative day were associated with 2.6 times higher odds of developing SSI (OR: 2.6, 95%CI: 1.3-3.9, value���<���0.05). Similar results were found for low BChE levels on the third postoperative day as they were associated with a. 2.53 times higher odds for developing SSI (OR: 2.5, 95%CI: 1.27-3.87, -value���<���0.05) when adjusted for other factors.
Conclusion: In conclusion, in this prospective observational study, low levels in the first and third postsurgery were associated with an increased risk for the development of SSIs but not sepsis.

Keywords

References

  1. J Hosp Infect. 2001 Mar;47(3):198-209 [PMID: 11247680]
  2. Int Wound J. 2004 Dec;1(4):247-73 [PMID: 16722874]
  3. Crit Care. 2022 Dec 6;26(1):377 [PMID: 36474266]
  4. Amino Acids. 2006 Nov;31(4):463-9 [PMID: 16583310]
  5. Crit Care Med. 2008 May;36(5):1404-11 [PMID: 18434909]
  6. Clin Chem Lab Med. 2002 Jan;40(1):60-4 [PMID: 11916272]
  7. Eur J Clin Chem Clin Biochem. 1995 Jan;33(1):11-4 [PMID: 7756436]
  8. Chest. 2006 Nov;130(5):1579-95 [PMID: 17099041]
  9. Ann Surg. 2006 Nov;244(5):758-63 [PMID: 17060769]
  10. Ann Surg. 2008 Apr;247(4):627-32 [PMID: 18362625]
  11. J Clin Med. 2023 Aug 11;12(16): [PMID: 37629287]
  12. Am J Infect Control. 1992 Oct;20(5):271-4 [PMID: 1332552]
  13. BMJ Open. 2021 Jul 6;11(7):e042857 [PMID: 34230011]
  14. World J Gastroenterol. 2005 Aug 7;11(29):4604-6 [PMID: 16052698]
  15. J Cancer Res Ther. 2008 Jan-Mar;4(1):21-5 [PMID: 18417898]
  16. Dis Colon Rectum. 2010 May;53(5):721-7 [PMID: 20389205]
  17. Mediators Inflamm. 2015;2015:274607 [PMID: 25762852]
  18. Mediators Inflamm. 2018 Apr 29;2018:1942193 [PMID: 29853783]
  19. Age Ageing. 2001 Jan;30(1):41-5 [PMID: 11322671]
  20. Crit Care. 2014 Jan 30;18(1):R24 [PMID: 24479557]
  21. J Inflamm Res. 2016 Nov 18;9:221-230 [PMID: 27920568]
  22. J Hosp Infect. 2005 Jun;60(2):93-103 [PMID: 15866006]
  23. Arch Surg. 2005 Feb;140(2):174-82 [PMID: 15724000]
  24. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80 [PMID: 10219875]
  25. BMJ. 2008 Oct 28;337:a1924 [PMID: 18957455]
  26. J Hosp Infect. 2001 Aug;48(4):267-74 [PMID: 11461127]
  27. Infect Control Hosp Epidemiol. 2008 Jul;29(7):623-9 [PMID: 18564917]
  28. Burns. 2021 Jun;47(4):863-872 [PMID: 33248805]
  29. Minerva Chir. 2011 Aug;66(4):323-7 [PMID: 21873967]
  30. Med Hypotheses. 2007;69(6):1272-6 [PMID: 17553629]
  31. Cancers (Basel). 2020 May 04;12(5): [PMID: 32375339]
  32. BMC Anesthesiol. 2022 Sep 16;22(1):293 [PMID: 36114455]
  33. Ann Surg. 2004 May;239(5):599-605; discussion 605-7 [PMID: 15082963]
  34. Ann Surg. 2022 Feb 1;275(2):363-370 [PMID: 32740245]
  35. J Am Coll Surg. 2007 Jun;204(6):1178-87 [PMID: 17544076]
  36. Langenbecks Arch Surg. 2023 Jun 6;408(1):227 [PMID: 37280384]
  37. J Intensive Care. 2017 May 26;5:29 [PMID: 28560042]
  38. Age Ageing. 2011 Sep;40(5):621-6 [PMID: 21576115]
  39. World J Surg. 2008 Jun;32(6):1142-6 [PMID: 18338205]
  40. J Gastrointest Surg. 2010 Jul;14(7):1090-8 [PMID: 20473578]
  41. Arch Dis Child. 1963 Aug;38:343-8 [PMID: 14058808]
  42. J Hosp Infect. 2008 Jul;69(3):230-48 [PMID: 18550218]
  43. PLoS One. 2022 Jul 8;17(7):e0271119 [PMID: 35802656]
  44. Eur J Clin Nutr. 2006 Feb;60(2):203-9 [PMID: 16234837]
  45. Ann Surg. 2023 Nov 1;278(5):e988-e994 [PMID: 37309899]
  46. JAMA. 2023 Jan 17;329(3):244-252 [PMID: 36648463]

Word Cloud

Created with Highcharts 10.0.0colorectalBChElevelssitesurgerySSIprospectivestudysurgical052infectionsSSIsriskinfectionpostoperativethirdday4-value���<���0lowassociatedpredictiveButyrylcholinesteraseresultsremainsassessBChE'ssingle-centerpatientsassociationdevelopmentpostsurgeryvsadjustedfactorsfirst6timeshigheroddsdevelopingOR:95%CI:1Introduction:Surgicalremainsignificantconcernwarrantseffectivemarkerspromptdiagnosistreatmentnon-specificcholinesteraseenzymecorrelatedhepaticdysfunctionprogressionrecentlyinfectiousdiseasessepticshockongoingresearchutilitymultiplesystemicinflammatoryconditionsWhetherpreliminarycantranslatedpredictingquestionaimedpotentialmarkeranastomoticleaksMaterialsmethods:11/2019-05/2023enrolled402underwentmeasuredfourtimepointsprimaryendpointsfocusedcomplicationsparticularlyknownpredictorsutilizedconstructmultivariablemodelsindependentResults:fifthsignificantlylowermean390���KU/L54���KU/L14���KU/L73���KU/L-testrespectivelyHowevermultivariateanalysisrevealed3-39value���<���0Similarfound53527-387Conclusion:conclusionobservationalincreasedsepsiscorrelateseveritysurgery:butyrylcholinesteraseinflammationprediction

Similar Articles

Cited By